Breast Cancer Trial, Recruiting NCT05933733 Sponsor: Samsung Medical Center Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05933733
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 to 100 years old
  • People who have already completed standard treatment for breast cancer (such as surgery, radiation, or chemotherapy) for their first diagnosis
  • People whose breast cancer has come back in the same area (chest, nearby lymph nodes, or surrounding tissue) but has not spread to other parts of the body
  • People who have a treatment plan in place to address the cancer that has come back locally
  • People who are willing and able to provide their informed consent to participate

Who may not be able to join:

  • People who are not expected to be able to follow the study's requirements and procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Haeyoung Kim, Samsung Medical Center

Phone: 82-2-3410-2612

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 July 2023
Est. completion
1 July 2028

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Progression-free survival; Rate of adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov